Who are the key players in China Kidney Stone Management Devices industry?

The top 5 players in the China Kidney Stone Management Devices industry include Dornier MedTech, Boston Scientific, Olympus Corporation, Stryker, and Shenzhen Huikang Medical Apparatus. These companies lead the market with innovative stone-breaking technologies, extensive product portfolios, robust distribution networks, and localized R&D efforts targeting China’s unique patient needs.

What is the China Kidney Stone Management Devices growth?

China’s Kidney Stone Management Devices market has experienced robust growth, with a CAGR of over 8% in recent years. Companies like Boston Scientific have expanded their presence by introducing advanced minimally invasive products, capitalizing on rising kidney stone incidence, increased healthcare spending, and enhanced diagnostic capabilities.

Which segment accounted for the largest China Kidney Stone Management Devices share?

The largest share in China’s Kidney Stone Management Devices market is held by the hospitals segment. Hospitals dominate due to their advanced infrastructure, availability of skilled professionals, and high patient inflow for stone management procedures, including lithotripsy and ureteroscopy, making them the primary users of these devices.

What are the factors driving the China Kidney Stone Management Devices?

Key drivers include a rising prevalence of kidney stones, increasing adoption of minimally invasive procedures, and supportive government healthcare initiatives. For example, Olympus Corporation leverages the trend toward less invasive treatments and new reimbursement policies to expand its reach in high-demand regions across China.

Which type accounted for the largest China Kidney Stone Management Devices share?

Extracorporeal Shock Wave Lithotripsy (ESWL) devices account for the largest share in China. Their non-invasive nature, high success rate, and ability to treat various stone sizes efficiently underpin their popularity, making them the preferred option in both public and private medical facilities nationwide.

Home Medical Devices

China Kidney Stone Management Devices Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: China Kidney Stone Management Devices
Brand: Bussiness Insights

China Kidney Stone Management Devices Market: by Type (Lithotripters, Ureteroscopes, Nephroscopes, Stone Retrieval Devices, Ureteral Stents, Consumables), Application (Ureteral Stones, Kidney Stones, Bladder Stones, Urethral Stones, Others), Distribution Channels (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Retail Pharmacies, Online Pharmacies, Others), Technology (Extracorporeal Shock Wave Lithotripsy, Laser Lithotripsy, Ultrasound Lithotripsy, Intracorporeal Lithotripsy, Electrohydraulic Lithotripsy, Others), Organization Size (Small, Medium, Large) and By China Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20227 | Author: Mike

RD TOC Segmentation Research Methodology Request For Free Sample

China Kidney Stone Management Devices Market Outlook 2025-2035

The China kidney stone management devices market is experiencing accelerated growth, driven by advancements in minimally invasive technologies and greater awareness of early detection. The market, segmented by device type, application, distribution channel, technology, and organization size, reveals expanding opportunities as demand for efficient, patient-friendly treatment rises. With a base year of 2025, the market is forecast to achieve robust growth through 2035 as healthcare infrastructure in China improves and the prevalence of kidney stone disease increases among an aging population. Industry leaders are focusing on innovative approaches, such as enhanced lithotripsy and laser-guided devices, while new regional entrants underscore mounting competitive intensity.

Latest Market Dynamics

Key Drivers

Rising prevalence of urolithiasis in China, coupled with lifestyle changes and dietary patterns, is significantly increasing demand for advanced kidney stone management devices. Companies like Boston Scientific and Olympus are deploying innovative minimally invasive solutions.

Adoption of laser lithotripsy and digital flexible ureteroscopes is gaining momentum, providing higher efficacy and safety. Karl Storz SE & Co. KG and Olympus Corporation have ramped up launches of these next-generation devices in China.
Integration of artificial intelligence in diagnostic and treatment planning is emerging, with Dornier MedTech partnering on AI-based lithotripter upgrades for improved stone targeting and reduced procedural times.

Growing telehealth and remote consultation demand is opening channels for device companies to provide training, maintenance, and post-treatment care. Boston Scientific (Shanghai) Co., Ltd. is piloting virtual consultations for hospital staff.
Expansion into pediatric nephrolithiasis solutions, where minimally invasive and precise devices are required, provides an untapped market—an opportunity recognized by Cook Medical with targeted product lines.

Regional disparities in device adoption rates, with rural areas lagging in access to advanced technologies, challenge market penetration—particularly addressed by Siemens Healthineers’ focus on affordable solutions.
Regulatory complexity and evolving compliance requirements for imported and locally manufactured devices can delay market entry and product updates, impacting both global players like Stryker and domestic firms.

High capital investment for advanced lithotripsy systems and recurring costs for consumables can restrain procurement, particularly in lower-tier hospitals. Coloplast Group’s cost-effective alternatives are gaining traction.
Concerns over device-associated complications—such as infection risk with reusable endoscopes—have prompted further scrutiny, impacting market acceptance and necessitating new safety features from players like EMS Electro Medical Systems.

In 2025, the market for kidney stone management devices in China is dominated by lithotripters, reflecting ongoing clinical preference for non-invasive stone breakdown solutions. This segment leads with a significant share, propelled by continuous improvements in shock wave and laser-based lithotripters. Ureteroscopes and stone retrieval devices also hold considerable shares, as endoscopic management remains the standard for complex and recurrent cases. The share distribution underscores the shift toward versatile, combination approaches for kidney stone management and highlights opportunities for innovation in reusable and single-use devices.

Kidney stones themselves represent the single largest application for these devices across China in 2025, accounting for a decisive market share. Close behind are ureteral stone interventions, owing to advancements in flexible ureteroscopy, while bladder stone management holds a moderate percentage. This reflects the clinical case mix seen in both institutional and ambulatory care environments and validates the continued need for accurate and specialized devices for diverse stone locations within the urinary tract.

The China kidney stone management devices market is set for substantial expansion, with revenue expected to rise from 326 million USD in 2020 to over 985 million USD by 2035. This growth is underpinned by surging procedure volumes, greater implementation of advanced technologies in both urban and rural healthcare settings, and government policies supporting imported and localized medical devices. The revenue trajectory illustrates healthy year-over-year increases, reflecting robust demand across all user settings in the next decade.

Year-over-year (YOY) growth in the China kidney stone management devices market will peak at over 12% in the early 2020s as adoption accelerates. As the market matures and new-generation devices become standard of care, YOY growth is expected to moderate, stabilizing around 8% by 2035. This pattern reflects a transition from a phase of rapid expansion to steady, innovation-driven maintenance, supported by recurring replacement and upgrade cycles.

Eastern China dominates the regional market landscape with the largest share, reflecting high population density, advanced hospital systems, and a concentration of specialty medical centers. Northern China follows, driven by major metropolitan hubs, while Southern and Western regions are increasingly capturing share due to ongoing infrastructure outsourcing and digital health initiatives. This regional breakup emphasizes where the highest device utilization and revenue generation will occur in the near term.

In 2025, international medtech giants maintain strong positions within China’s kidney stone management market. Boston Scientific leads, closely followed by Olympus Corporation and Dornier MedTech, each leveraging deep portfolios and well-established distribution channels. Domestic firms are steadily growing, but the market remains shaped by technological leadership, clinical credibility, and investment in local innovation networks.

Hospitals represent the major buyer segment for kidney stone devices in China, accounting for the largest market share due to their capacity for complex treatments and surgical procedures. Ambulatory surgical centers constitute a growing segment, boosted by demand for day-care minimally invasive procedures. Retail and online pharmacies represent a small but expanding share, reflecting increasing patient empowerment for post-surgical care and consumables.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	442
Regions	Eastern China, Northern China, Southern & Western China
Segments	Lithotripters, Ureteroscopes, Nephroscopes, Stone Retrieval Devices, Ureteral Stents, Consumables; Ureteral Stones, Kidney Stones, Bladder Stones, Urethral Stones, Others.
Players	Boston Scientific Corporation, Olympus Corporation, Dornier MedTech, Karl Storz SE & Co. KG, Cook Medical, Siemens Healthineers, Boston Scientific (Shanghai) Co., Ltd., Stryker Corporation, EMS Electro Medical Systems, Coloplast Group, Richard Wolf GmbH, Bard Medical, Lumenis Be Ltd, HealthTronics Inc, Allengers Medical Systems Ltd

June 2024: Olympus Corporation introduces the latest digital ureteroscope series, designed for improved maneuverability and visualization in Chinese hospitals.
June 2024: Boston Scientific announces enhanced localized after-sales service centers in Shanghai, focusing on kidney stone device support.
July 2024: Dornier MedTech partners with a major telehealth provider to pilot AI-powered lithotripsy assessment and remote-guided procedures in Eastern China.
July 2024: Siemens Healthineers debuts affordable smart shock wave lithotripters for lower-tier hospitals, targeting rural regional expansion.
August 2024: Cook Medical launches its new pediatric kidney stone management portfolio, addressing a gap in child and adolescent care.

About the Author

Mike

Lead Industry Analyst

Mike is a Lead Industry Analyst specializing in market research, industry analysis, and business consulting across Medical Devices. Mike brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Mike has helped organizations translate data into actionable growth strategies.

Medical DevicesMarket ResearchIndustry AnalysisStrategic Consulting

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Download Sample

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Speak to Analyst

China Kidney Stone Management Devices Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

China Kidney Stone Management Devices Market Outlook 2025-2035

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

China Kidney Stone Management Devices Market Share by Type, 2025

China Kidney Stone Management Devices Market Share by Application, 2025

China Kidney Stone Management Devices Market Revenue (USD Million), 2020-2035

China Kidney Stone Management Devices Market YOY Growth (%), 2020-2035

China Kidney Stone Management Devices Market Share by Regions (%), 2025

China Kidney Stone Management Devices Market Players Share (%), 2025

China Kidney Stone Management Devices Market Buyers Share (%), 2025

Study Coverage

Key Recent Developments

Frequently Asked Questions

About the Author

Related Reports